Advanced Search
XIANG Ming-yue, LIU Jian-guo. Clinical and Hematology Analysis of Bone Marrow Involuement in NHL[J]. Cancer Research on Prevention and Treatment, 2007, 34(08): 610-613. DOI: 10.3971/j.issn.1000-8578.2347
Citation: XIANG Ming-yue, LIU Jian-guo. Clinical and Hematology Analysis of Bone Marrow Involuement in NHL[J]. Cancer Research on Prevention and Treatment, 2007, 34(08): 610-613. DOI: 10.3971/j.issn.1000-8578.2347

Clinical and Hematology Analysis of Bone Marrow Involuement in NHL

More Information
  • Corresponding author:

    XIANG Ming-yue

  • Received Date: March 15, 2007
  • Revised Date: May 30, 2007
  • Objective  To discuss the clinical features of NHL marrow invasion and it s' relationship with hematology. Methods  Analysis the clinical datum of 95 cases of NHL marrow invasion, make routine bone marrow aspiration and hematology test . Results  In those patient s with marrow invasion, 4 cases in I phase (4. 2 %), 12 cases in II phase (12. 6 %), 36 cases in Ⅲphase (37. 9 %) and 43 cases in Ⅳphase (47. 4 %) ; small lymphocytic 、diffuse cleaved cell 、lymphoblastic lymphoma are main pathologic types ;patients with mediastinal lymphadenectasis、splenomegaly and spleen violations are prone to catch bone marrow involvement ;56 cases of anemia in patients with bone marrow involuement ( 58. 9 %), 42 patients with thrombocytopenia (44. 2 %), 27 cases with leukopenia (28. 4 %), 49 cases of patient s leukocyte increased (51. 6 %), so, anemia is common ; three were 30 cases with three items abnormal (31. 6 %) and 65 cases with one item abnormal at least (68. 4 %), the incidence of abnormal peripheral blood in leukocythemia patients were higher than that in patient s with bone marrow infilt ration, Particularly the patients with increased leukocyte or three items abnormalities were more common in leukemia ; Abnormal cells in peripheral blood were observed in 66 cases (69. 5 %) ; chemotherapy efficiency reached 65. 2 % in the patients with bone marrow involuement, the median survival time was 11. 5 months. Conclusion  Marrow invasion in NHL patients is related to clinical stage, pathological types and sites of involvement, bone marrow check should be done to the newly diagnosed NHL patients conventionally as well as the peripheral blood.
  • Related Articles

    [1]CHU Xuelei, AN Chen, XI Lingze, XIE Hongting, ZONG Mingtong, XUE Peng, ZHU Shijie. Predictive Value of Immune Inflammation Combined with Liver Function Hematological Indicators for Metastasis of Colorectal Cancer[J]. Cancer Research on Prevention and Treatment, 2024, 51(9): 764-771. DOI: 10.3971/j.issn.1000-8578.2024.24.0211
    [2]YUAN Fangqin, WANG Teng, GUO Wenjie, HE Xia, YIN Li. Prognostic Value of Hematological Indicators in Children and Adolescents with Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2023, 50(6): 581-586. DOI: 10.3971/j.issn.1000-8578.2023.22.1446
    [3]NAN Yingyu, YAO Xuan, YANG Zhong. Role of Exosome in Microenvironment of Hematological Malignancies and Its Diagnostic and Therapeutic Potential[J]. Cancer Research on Prevention and Treatment, 2021, 48(1): 93-97. DOI: 10.3971/j.issn.1000-8578.2021.20.0617
    [4]YU Xuedi, SHE Chunhua, SUN Zengfeng, LIU Jingjing, MA Li, LI Wenliang. Predictive Value of Preoperative Hematologic Inflammatory Markers in Prognostic of Glioma Patients[J]. Cancer Research on Prevention and Treatment, 2019, 46(8): 714-719. DOI: 10.3971/j.issn.1000-8578.2019.19.0163
    [5]GE Xueke, SONG Yuzhi, ZHEN Chanjun, LI Jing, LIU Ming, QIAO Xueying. Relationship of Irradiated Dosimetric Parameters of Bone Marrow and Hematologic Toxicities in Locally Advanced Adenocarcinoma of Esophagogastric Junction Patients Treated with Preoperative Chemoradiotherapy[J]. Cancer Research on Prevention and Treatment, 2017, 44(12): 804-810. DOI: 10.3971/j.issn.1000-8578.2017.17.0133
    [6]TANG Yan, YUAN Yawei. Risk Factors Associated with Hematologic Toxicity in Concurrent Chemoradiotherapy and IMRT for Cervical Cancer[J]. Cancer Research on Prevention and Treatment, 2016, 43(4): 277-281. DOI: 10.3971/j.issn.1000-8578.2016.04.008
    [7]LUO Rui, SUN Jun-mo, LONG Qing-yun, TIAN Zhi-xiong. Non-Hodgkin s Lymphoma of Nasal Cavity:CT Diagnosis and Clinical Prognosis[J]. Cancer Research on Prevention and Treatment, 2004, 31(10): 623-626. DOI: 10.3971/j.issn.1000-8578.2563
    [8]ZHOU Fang, WANG Jian Min, ZHANG Wei Ping, FENG Cao bo, SONG Xian min, ZHOU Hong, GONG Sheng lan, DING Xiao qin. A Clinical Comparison of CD34~+ Selected Autologous Peripheral Blood Stem Cells Transplantation in Malignant Hematologic Disease[J]. Cancer Research on Prevention and Treatment, 2004, 31(06): 362-364. DOI: 10.3971/j.issn.1000-8578.847
    [9]LIU Qi fa, ZHANG Yu, WEI Yong qiang, XU Dan, SUN Jing, XU Bing, LIU Xiao li, FENG Ru, MENG Fan yi, ZHOU Shu yun. The Effect s Analysis of Hematopoietic Stem Cell Transplantation(HSCT) for Hematological Malignancies[J]. Cancer Research on Prevention and Treatment, 2004, 31(06): 356-358. DOI: 10.3971/j.issn.1000-8578.848
    [10]Yu Zhiying, . Radiotherapy of Non-Hodgkins Lymphoma(NHL) of the nasal cavity[J]. Cancer Research on Prevention and Treatment, 1998, 25(1): 64-66.

Catalog

    LIU Jian-guo

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Article views (3041) PDF downloads (1653) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return